HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuronal activation in the central nervous system of rats in the initial stage of chronic kidney disease-modulatory effects of losartan and moxonidine.

Abstract
The effect of mild chronic renal failure (CRF) induced by 4/6-nephrectomy (4/6NX) on central neuronal activations was investigated by c-Fos immunohistochemistry staining and compared to sham-operated rats. In the 4/6 NX rats also the effect of the angiotensin receptor blocker, losartan, and the central sympatholyticum moxonidine was studied for two months. In serial brain sections Fos-immunoreactive neurons were localized and classified semiquantitatively. In 37 brain areas/nuclei several neurons with different functional properties were strongly affected in 4/6NX. It elicited a moderate to high Fos-activity in areas responsible for the monoaminergic innervation of the cerebral cortex, the limbic system, the thalamus and hypothalamus (e.g. noradrenergic neurons of the locus coeruleus, serotonergic neurons in dorsal raphe, histaminergic neurons in the tuberomamillary nucleus). Other monoaminergic cell groups (A5 noradrenaline, C1 adrenaline, medullary raphe serotonin neurons) and neurons in the hypothalamic paraventricular nucleus (innervating the sympathetic preganglionic neurons and affecting the peripheral sympathetic outflow) did not show Fos-activity. Stress- and pain-sensitive cortical/subcortical areas, neurons in the limbic system, the hypothalamus and the circumventricular organs were also affected by 4/6NX. Administration of losartan and more strongly moxonidine modulated most effects and particularly inhibited Fos-activity in locus coeruleus neurons. In conclusion, 4/6NX elicits high activity in central sympathetic, stress- and pain-related brain areas as well as in the limbic system, which can be ameliorated by losartan and particularly by moxonidine. These changes indicate a high sensitivity of CNS in initial stages of CKD which could be causative in clinical disturbances.
AuthorsMiklós Palkovits, Katarína Šebeková, Kristina Simon Klenovics, Anton Kebis, Gholamreza Fazeli, Udo Bahner, August Heidland
JournalPloS one (PLoS One) Vol. 8 Issue 6 Pg. e66543 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID23818940 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Angiotensin II Type 1 Receptor Blockers
  • Antihypertensive Agents
  • Imidazoles
  • Proto-Oncogene Proteins c-fos
  • moxonidine
  • Losartan
Topics
  • Angiotensin II Type 1 Receptor Blockers (pharmacology)
  • Animals
  • Antihypertensive Agents (pharmacology)
  • Brain (drug effects, metabolism)
  • Central Nervous System (drug effects, metabolism)
  • Imidazoles (pharmacology)
  • Immunohistochemistry
  • Kidney (physiopathology, surgery)
  • Locus Coeruleus (drug effects, metabolism)
  • Losartan (pharmacology)
  • Male
  • Nephrectomy (methods)
  • Neurons (drug effects, metabolism)
  • Proto-Oncogene Proteins c-fos (metabolism)
  • Rats
  • Rats, Wistar
  • Renal Insufficiency, Chronic (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: